Thema: Raises
Guggenheim, Raises
Guggenheim Raises Price Target for Assembly Biosciences to $39 on Strong Clinical Data - Foto: ĂĽber boerse-global.de
Guggenheim Raises Price Target for Assembly Biosciences to $39 on Strong Clinical Data
